When an Israeli Company Becomes American on Paper

This article was originally published on Funder in October 2026.

When an Israeli Company Becomes American on Paper

WBecoming more American commercially does not necessarily mean becoming less Israeli operationally. Cellebrite is a good example.
By Michael D. Ehrenstein

Israeli technology companies often reach a point where their largest customers, investors and growth opportunities sit in the United States. At that stage, corporate structure stops being an administrative detail. It becomes part of business strategy.

Cellebrite illustrates the point.

The Israeli-founded digital-intelligence company has built a substantial American presence while maintaining major operations and technological roots in Israel. Its U.S. business serves law-enforcement, defense, intelligence and enterprise customers, and it has invested heavily in satisfying the cybersecurity and compliance requirements that come with sensitive American government markets.

The strategic question is straightforward: how does an Israeli company get closer to the American market without disrupting the people, engineering culture and operating capabilities that made it valuable?

Sometimes the answer is to change the structure without changing the operating engine.

Structure Can Follow Strategy

The United States offers Israeli companies deep capital markets, large strategic customers, sophisticated investors, government procurement opportunities and access to the world’s largest technology ecosystem.

But accessing those opportunities can require more than opening a U.S. sales office.

A company’s legal domicile can affect how investors view it, how government customers evaluate it, how transactions are structured and how regulators oversee it. For companies selling sensitive technology, those issues become especially important.

A deeper U.S. corporate structure may therefore improve access to capital and customers without requiring a company to relocate the engineers, founders or research teams that created its competitive advantage.

The legal structure can move closer to the market while the operating core remains where it works best.

Decart Shows the Other Side of the Choice

The recent Decart episode offers a useful counterpoint.

Anthropic reportedly explored acquiring the Israeli AI company for roughly $6 billion. The transaction ultimately fell apart because Anthropic wanted Decart’s founders and key personnel to relocate from Tel Aviv to San Francisco, and the Israeli team resisted.

That is important because corporate integration and operational relocation are not the same decision.

A buyer may want the technology, team and intellectual property. But the founders may conclude that the environment in which the company was built remains part of the asset itself.

That creates a real strategic tension.

A U.S. structure can provide scale, capital and customers. A relocation requirement may weaken the culture, talent network and operating model that made the target attractive in the first place.

Cellebrite and Decart therefore sit on different sides of the same question.

Cellebrite shows how a company can move closer to the American market through structure. Decart shows that there may be limits to how far that integration should go when the operating base itself creates value.

The Real Asset May Still Be in Israel

Many Israeli technology companies become attractive to American customers precisely because of what they developed in Israel.

Israel has deep concentrations of engineering talent, cybersecurity expertise, military experience and entrepreneurial speed. Companies operating in that environment often develop technology under unusual pressure and against unusually difficult problems.

Those capabilities do not disappear when the corporate structure changes.

But neither should companies assume that they can move those capabilities without cost.

Relocation can weaken recruiting, culture, informal networks and the habits that produced the company’s original success. Those losses may not appear clearly in an acquisition model, but they can be very real.

The better question is therefore not whether an Israeli company should move closer to the United States.

It is:

Which parts of the company should move closer to the market, and which parts should remain where they create the most value?

Preserve the Source of the Advantage

For one company, the answer may be a U.S. subsidiary. For another, it may mean American manufacturing, a U.S. headquarters, a different parent-company structure or a change in domicile.

For another, the answer may be to reject a transaction that requires moving the operating core.

Each option carries consequences.

A deeper U.S. structure may create additional tax, regulatory, governance and litigation exposure. It may also open doors to customers, government contracts and investors that would otherwise remain difficult to reach.

The decision should begin with commercial objectives, not symbolism.

Cellebrite shows that structure can move toward the market. Decart shows that the operating core does not always have to follow. The best strategy is the one that expands access without sacrificing the source of the company’s value.

Michael Ehrenstein, Esq. is a founding partner at the U.S. law firm Ehrenstein | Sager, specializing in commercial law, complex litigation, and high-stakes international arbitration.

Legal Disclaimer: This article does not constitute legal or tax advice. Its purpose is to raise awareness regarding U.S. compliance issues. Israeli businesses should consult with qualified U.S. legal and tax professionals to receive advice tailored to their specific operations.